TERRINNE CRAFT: Open Payments
NPI 1144867482 · GRAND PRAIRIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,380 in 77 payments from 14 companies in 2025. Trend: 2023 $33 · 2024 $1,050 · 2025 $1,380
Food & beverage: $1,380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $241 |
| Lilly USA, LLC | 12 | $225 |
| Novo Nordisk Inc | 11 | $209 |
| PFIZER INC. | 10 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
Products named: JARDIANCE, NURTEC ODT, Wegovy, VRAYLAR, MOUNJARO, Kerendia, Ozempic, UBRELVY.
Industry payments across TX — which companies pay providers there.
